Circulating CD14(+) monocytes in patients with aortic stenosis

Sara Shimoni1, Valery Meledin1, Iris Bar1

  • 1Heart Institute, Kaplan Medical Center, Rehovot, Israel.

Insights

Patients with calcific aortic stenosis (AS) have more circulating CD14(+) monocytes. Higher monocyte counts correlate with more severe AS, suggesting inflammation plays a role in advanced stages of this valvular heart disease.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathophysiology

Background:

  • Calcific aortic stenosis (AS) involves inflammation, fibrosis, and calcification, similar to atherosclerosis.
  • Monocytes are implicated in these pathological processes, but their specific role in AS remains unclear.

Purpose of the Study:

  • To investigate the association between circulating CD14(+) monocytes (both apoptotic and non-apoptotic) and features of calcific aortic stenosis.

Main Methods:

  • Flow cytometry was used to quantify CD14(+) monocytes and apoptotic monocytes in 54 patients with significant AS and 33 controls.
  • Patients with AS had an aortic valve area of 0.74 ± 0.27 cm(2).

Main Results:

  • No significant differences in risk factors or other vascular diseases were found between AS patients and controls.
  • AS patients showed significantly higher numbers of CD14(+) monocytes compared to controls (9.9% ± 4.9% vs. 7.7% ± 3.9%, P = 0.03).
  • Monocyte counts correlated with age, AS presence, and severity, and were inversely related to aortic valve area in AS patients.

Conclusions:

  • Significant AS is characterized by an increased number of circulating CD14(+) monocytes.
  • The inverse correlation between monocyte count and aortic valve area suggests inflammation is active even in severe, calcified stages of AS.
Abstract